Overall these data indicate that the levels of expression of Polβ and MLH1 are very heterogeneous in MSI and MSS gastric cancers and suggest that there is a regulatory circuit, highlighted by PC3, where these two enzymes are inversely regulated. The gene discussed is MLH1; the disease is gastric cancer.